Barrington raised the firm’s price target on Merit Medical (MMSI) to $109 from $106 and keeps an Outperform rating on the shares. The firm views the company’s Q4 report as strong.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical Systems: Strong Q4 Beat, Upbeat 2026 Outlook, and Margin Expansion Underpin Buy Rating Despite Lowered Price Target
- Merit Medical Posts Strong Q4 Results, Raises 2026 Outlook
- Merit Medical reports Q4 EPS $1.04, consensus 95c
- Merit Medical sees FY26 EPS $4.01-$4.15, consensus $4.04
- MMSI Upcoming Earnings Report: What to Expect?